Mattsson Jan
- SEC CIK
- 0001687436
No open-market purchases or sales filed in the past year.
Current role at each company
- ALBO Albireo Pharma, Inc.Chief Scientific Officeras of Mar 2, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mattsson Jan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2023 (view filing) | Jan 23 | Same day | Mattsson JanChief Scientific Officer | SSale | −197 | $43.80 | −$8.63K | −0.4%54.5K after | |
| Jan 20, 2023 (view filing) | Jan 19 | 1 day | Mattsson JanChief Scientific Officer | SSale | −3.09K | $43.80 | −$135.3K | −5.3%54.7K after | |
| Oct 25, 2022 (view filing) | Oct 24 | 1 day | Mattsson JanChief Scientific Officer | SSale | −202 | $19.58 | −$3.96K | −0.3%57.8K after | |
| Jul 25, 2022 (view filing) | Jul 22 | 3 days | Mattsson JanChief Scientific Officer | SSale | −205 | $24.68 | −$5.06K | −0.4%58.0K after | |
| Apr 25, 2022 (view filing) | Apr 22 | 3 days | Mattsson JanChief Scientific Officer | SSale | −200 | $32.92 | −$6.58K | −0.3%58.2K after | |
| Jan 25, 2022 (view filing) | Jan 24 | 1 day | Mattsson JanChief Scientific Officer | SSale | −808 | $24.88 | −$20.1K | −1.4%58.4K after |